GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Genotech Corp (XKRX:066830) » Definitions » Beneish M-Score

Genotech (XKRX:066830) Beneish M-Score : -1.77 (As of May. 27, 2024)


View and export this data going back to 2016. Start your Free Trial

What is Genotech Beneish M-Score?

The zones of discrimination for M-Score is as such:

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator.
An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Warning Sign:

Beneish M-Score -1.77 higher than -1.78, which implies that the company might have manipulated its financial results.

The historical rank and industry rank for Genotech's Beneish M-Score or its related term are showing as below:

XKRX:066830' s Beneish M-Score Range Over the Past 10 Years
Min: -3.61   Med: -2.5   Max: 0.87
Current: -1.77

During the past 9 years, the highest Beneish M-Score of Genotech was 0.87. The lowest was -3.61. And the median was -2.50.


Genotech Beneish M-Score Historical Data

The historical data trend for Genotech's Beneish M-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Genotech Beneish M-Score Chart

Genotech Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Beneish M-Score
Get a 7-Day Free Trial Premium Member Only -3.41 -1.79 0.87 -3.61 -1.77

Genotech Semi-Annual Data
Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Beneish M-Score Get a 7-Day Free Trial Premium Member Only -3.41 -1.79 0.87 -3.61 -1.77

Competitive Comparison of Genotech's Beneish M-Score

For the Biotechnology subindustry, Genotech's Beneish M-Score, along with its competitors' market caps and Beneish M-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Genotech's Beneish M-Score Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Genotech's Beneish M-Score distribution charts can be found below:

* The bar in red indicates where Genotech's Beneish M-Score falls into.



Genotech Beneish M-Score Calculation

The M-score was created by Professor Messod Beneish. Instead of measuring the bankruptcy risk (Altman Z-Score) or business trend (Piotroski F-Score), M-score can be used to detect the risk of earnings manipulation. This is the original research paper on M-score.

The M-Score Variables:

The M-score of Genotech for today is based on a combination of the following eight different indices:

M=-4.84+0.92 * DSRI+0.528 * GMI+0.404 * AQI+0.892 * SGI+0.115 * DEPI
=-4.84+0.92 * 1.9406+0.528 * 1.5938+0.404 * 1.0385+0.892 * 0.5283+0.115 * 0.8863
-0.172 * SGAI+4.679 * TATA-0.327 * LVGI
-0.172 * 1.903+4.679 * -0.024366-0.327 * 0.3222
=-1.77

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Dec23) TTM:Last Year (Dec22) TTM:
Total Receivables was ₩155 Mil.
Revenue was ₩2,750 Mil.
Gross Profit was ₩1,095 Mil.
Total Current Assets was ₩6,435 Mil.
Total Assets was ₩12,233 Mil.
Property, Plant and Equipment(Net PPE) was ₩4,430 Mil.
Depreciation, Depletion and Amortization(DDA) was ₩367 Mil.
Selling, General, & Admin. Expense(SGA) was ₩252 Mil.
Total Current Liabilities was ₩322 Mil.
Long-Term Debt & Capital Lease Obligation was ₩0 Mil.
Net Income was ₩-263 Mil.
Gross Profit was ₩0 Mil.
Cash Flow from Operations was ₩35 Mil.
Total Receivables was ₩151 Mil.
Revenue was ₩5,206 Mil.
Gross Profit was ₩3,303 Mil.
Total Current Assets was ₩7,259 Mil.
Total Assets was ₩13,233 Mil.
Property, Plant and Equipment(Net PPE) was ₩4,548 Mil.
Depreciation, Depletion and Amortization(DDA) was ₩331 Mil.
Selling, General, & Admin. Expense(SGA) was ₩250 Mil.
Total Current Liabilities was ₩1,079 Mil.
Long-Term Debt & Capital Lease Obligation was ₩0 Mil.




1. DSRI = Days Sales in Receivables Index

Measured as the ratio of Revenue in Total Receivables in year t to year t-1.

A large increase in DSR could be indicative of revenue inflation.

DSRI=(Receivables_t / Revenue_t) / (Receivables_t-1 / Revenue_t-1)
=(155.106 / 2750.326) / (151.293 / 5205.993)
=0.056395 / 0.029061
=1.9406

2. GMI = Gross Margin Index

Measured as the ratio of gross margin in year t-1 to gross margin in year t.

Gross margin has deteriorated when this index is above 1. A firm with poorer prospects is more likely to manipulate earnings.

GMI=GrossMargin_t-1 / GrossMargin_t
=(GrossProfit_t-1 / Revenue_t-1) / (GrossProfit_t / Revenue_t)
=(3302.815 / 5205.993) / (1094.816 / 2750.326)
=0.634426 / 0.398068
=1.5938

3. AQI = Asset Quality Index

AQI is the ratio of asset quality in year t to year t-1.

Asset quality is measured as the ratio of non-current assets other than Property, Plant and Equipment to Total Assets.

AQI=(1 - (CurrentAssets_t + PPE_t) / TotalAssets_t) / (1 - (CurrentAssets_t-1 + PPE_t-1) / TotalAssets_t-1)
=(1 - (6434.698 + 4430.346) / 12233.383) / (1 - (7259.247 + 4548.239) / 13232.762)
=0.111853 / 0.107708
=1.0385

4. SGI = Sales Growth Index

Ratio of Revenue in year t to sales in year t-1.

Sales growth is not itself a measure of manipulation. However, growth companies are likely to find themselves under pressure to manipulate in order to keep up appearances.

SGI=Sales_t / Sales_t-1
=Revenue_t / Revenue_t-1
=2750.326 / 5205.993
=0.5283

5. DEPI = Depreciation Index

Measured as the ratio of the rate of Depreciation, Depletion and Amortization in year t-1 to the corresponding rate in year t.

DEPI greater than 1 indicates that assets are being depreciated at a slower rate. This suggests that the firm might be revising useful asset life assumptions upwards, or adopting a new method that is income friendly.

DEPI=(Depreciation_t-1 / (Depreciaton_t-1 + PPE_t-1)) / (Depreciation_t / (Depreciaton_t + PPE_t))
=(330.693 / (330.693 + 4548.239)) / (366.873 / (366.873 + 4430.346))
=0.06778 / 0.076476
=0.8863

Note: If the Depreciation, Depletion and Amortization data is not available, we assume that the depreciation rate is constant and set the Depreciation Index to 1.

6. SGAI = Sales, General and Administrative expenses Index

The ratio of Selling, General, & Admin. Expense(SGA) to Sales in year t relative to year t-1.

SGA expenses index > 1 means that the company is becoming less efficient in generate sales.

SGAI=(SGA_t / Sales_t) / (SGA_t-1 /Sales_t-1)
=(251.706 / 2750.326) / (250.367 / 5205.993)
=0.091519 / 0.048092
=1.903

7. LVGI = Leverage Index

The ratio of total debt to Total Assets in year t relative to yeat t-1.

An LVGI > 1 indicates an increase in leverage

LVGI=((LTD_t + CurrentLiabilities_t) / TotalAssets_t) / ((LTD_t-1 + CurrentLiabilities_t-1) / TotalAssets_t-1)
=((0 + 321.521) / 12233.383) / ((0 + 1079.476) / 13232.762)
=0.026282 / 0.081576
=0.3222

8. TATA = Total Accruals to Total Assets

Total accruals calculated as the change in working capital accounts other than cash less depreciation.

TATA=(IncomefromContinuingOperations_t - CashFlowsfromOperations_t) / TotalAssets_t
=(NetIncome_t - NonOperatingIncome_t - CashFlowsfromOperations_t) / TotalAssets_t
=(-262.924 - 0 - 35.158) / 12233.383
=-0.024366

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator. An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Genotech has a M-score of -1.77 signals that the company is likely to be a manipulator.


Genotech Beneish M-Score Related Terms

Thank you for viewing the detailed overview of Genotech's Beneish M-Score provided by GuruFocus.com. Please click on the following links to see related term pages.


Genotech (XKRX:066830) Business Description

Traded in Other Exchanges
N/A
Address
26-69, Gajeongbuk-ro, Yuseong-gu, Daejeon, KOR, 305-343
Genotech Corp is engaged in manufacturing basic pharmaceutical substances and biological agents.

Genotech (XKRX:066830) Headlines

No Headlines